Pyxis Oncology, Inc. (PYXS) analyst actions
Rating and price-target actions on PYXS in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the PYXS overview →
1 measured PYXS analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Pyxis Oncology Initiates New PYX-201 Combination Trial and Initiates Cohort Expansions of Ongoing Monotherapy Trial | Press release | +2.65% | +0.00% |
Keep exploring
More PYXS: earnings → · SEC filings → · PYXS overview →